Sanofi defends proposed class action alleging conspiracy to raise prices
Clients Sanofi-Aventis U.S. LLC
Jones Day is defending Sanofi-Aventis U.S. LLC against a proposed class action alleging that the company conspired with or through pharmacy benefit managers to raise prices for its diabetes drug, Lantus, in violation of federal and state antitrust, consumer protection, fraud, RICO, and employee benefit laws.
Chaires v. Novo Nordisk Inc., No. 17-cv-00699 (D.N.J.)